Highlights Apyx Medical Corporation

Equities

APYX

US03837C1062

Delayed Nasdaq Other stock markets 01:29:16 14/05/2024 am IST			5-day change	1st Jan Change
1.43 ^USD	-4.67%		+4.29%	-44.27%

09/05	Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024
09/05	Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (APYX) APYX MEDICAL CORPORATION Reports Q1 Revenue $10.2M	09/05	MT
Apyx Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
Apyx Medical Corporation Reaffirms Earnings Guidance for the Full Year Ending December 31, 2024	09/05	CI
Apyx Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	21/03	CI
Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024	21/03	CI
Apyx Medical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03	CI
North American Morning Briefing : Investors -2-	21/03	DJ
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	22/01	CI
Apyx Medical Reports Q4, Full-Year 2023 Preliminary Revenue	08/01	MT
Apyx Medical Corporation Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	08/01	CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Posts Q3 Revenue $12M, vs. Street Est of $15.4M	09/11	MT
Apyx Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
Apyx Medical Corporation Revises Earnings Guidance for the Year 2023	09/11	CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Reports Q2 Revenue $13.6M, vs. Street Est of $14.3M	11/23/11	MT
Apyx Medical Corporation Reaffirms Financial Guidance for the Year Ending December 31, 2023	11/23/11	CI
Apyx Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece	14/23/14	CI
Apyx Medical Corporation Updates Earnings Guidance for the Year Ending December 31, 2023	11/23/11	CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Posts Q1 Revenue $12.1M, vs. Street Est of $10.8M	11/23/11	MT
Apyx Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	11/23/11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Apyx Medical Corporation

Equities

APYX

US03837C1062

Highlights

Filters